Cocaine cardiotoxicity and ventricular disfunction in a young patient

Authors

DOI:

https://doi.org/10.11606/issn.2176-7262.v53i4p464-467

Keywords:

Ventricular Dysfunction, Heart Failure, Cardiotoxicity, Cocaine

Abstract

The use of psychoactive substances can induce cardiovascular complications. The purpose of this report is to describe the case of a young patient with dilated cardiomyopathy secondary to cocaine use. Patient with dyspnea for six months, with progressive worsening, paroxysmal nocturnal dyspnea, orthopnea, and lower limb edema. Physical examination showed tachycardia (110 bpm), with other vital signs without alterations, presence of crackling rales in the bases and middle fields, moderate volume ascites, and significant lower limb edema. Electrocardiogram showed sinus rhythm with left chamber overload; chest X-ray only marked cardiomegaly. The echocardiogram showed reduced left ventricular (LV) ejection fraction (7%), enlarged left atrium, and right ventricle (RV), with eccentric hypertrophy and severe left ventricular systolic dysfunction, with moderate RV dysfunction and pulmonary hypertension (39 mmHg). Resonance presented mild right atrial dilatation, RV with significant dilatation, significant biventricular systolic dysfunction, with diffuse hypokinesia, and myocardial fibrosis of non-coronary pattern. The reported case shows a diagnosis whose pathophysiological mechanism of dilated cardiomyopathy is not clear. The most coherent association of dilated cardiomyopathy presented by the patient is related to cocaine abuse, due to the long-term recurrent stimulus that excess catecholamines caused in the myocardium. Given the spectrum of cardiomyopathy, infarction, and arrhythmias that may potentially occur associated with cocaine use, the hypothesis of cardiotoxicity should be considered in the evaluation of a patient with a history of cocaine abuse.

Downloads

Download data is not yet available.

References

Hantson P. Mechanisms of toxic cardiomyopathy. Clinical Toxicology. 2018;57(1):1-9.

Lee C. Mechanisms of cardiotoxicity and the development of the heart failure. Critical Care Nursing Clinics. 2015;27(4),469-481.

Schwarts BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010;122:2558–2569.

Ghuran A, Nolan J. Recreational drug misue: issues for the cardiologist. Heart. 2000;83:627-633.

Havakuk O, Rezkalla SH, Kloner RA. The Cardiovascular Effects of Cocaine. J. Am. Coll. Cardiol. 2017;70(1):101-113.

Liaudet L, Calderari B, Pacher P. Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity. Heart failure reviews. 2014;19(6),815-824.

Alzghoul, BN et al. Cocaine Use and Pulmonary Hypertension. Am. J. 2020;125(2):282-288.

Rangel I, Amorim M, Gonçalves A, Sousa C, Bettencourt P, Macial MJ. Cardiomiopatia tóxica dilatada: reconhecendo uma doença potencialmente reversível. Arq Bras Cardiol. 2014;102(4):e37-e339.

Rump AF, Theisohn M, Klaus W. The pathophysiology of cocaine cardiotoxicity. Forensic Sci Int. 1995;71:103–115.

Mann DL, et al. Braunwald Tratado de Doenças Cardiovasculares. 10th ed. [place unknown: publisher unknown]; 2018. 68, Cardiomiopatias Químicas; p. 1663-1672

Published

2020-12-11

Issue

Section

Relato de Caso

How to Cite

1.
Souza K de C e, Viaro AL, Okusu AR, Bastos SO, Roballo CA, Ronconi TL. Cocaine cardiotoxicity and ventricular disfunction in a young patient. Medicina (Ribeirão Preto) [Internet]. 2020 Dec. 11 [cited 2024 May 19];53(4):464-7. Available from: https://revistas.usp.br/rmrp/article/view/165060